Surety Medicine 
Two chemical weapons destruction plant workers in protective equipment 

The possibility of exposure to nerve and mustard agent in the workplace can be assessed with a
well-defined, multi-step agent-specific patient evaluation process.                  -U.S. Army photo

May 2016 Surety Medicine Teleconference:

 AN APPROACH TO CONDUCTING 
 POTENTIAL EXPOSURE EVALUATIONS

Wednesday, 18 May 2016 will bring the next Surety Medicine Teleconference, at 1 pm (1300 hrs) Eastern Time.  The topic for May will be “An Approach to Conducting Potential Exposure Evaluations” related to nerve and mustard agent workers.  The presenter will be the Army Public Health Center’s Senior Surety Medicine Physician.

To receive access information for attending the presentation by dial-in audio or on your computer via Defense Collaboration Services (DCS), send an email request to:

usarmy.apg.medcom-aphc.mbx.surety-medicine@mail.mil


ALERT:
  FDA Simplifies Rule for Anthrax PEP

FDA APPROVES ANTHRAX VACCINE FOR POST-EXPOSURE PROPHYLAXIS

The US Food and Drug Administration (FDA) November 25, 2015 approved the current Anthrax Vaccine Adsorbed for use in combination with antibiotic therapy after a confirmed or suspected exposure to Bacillus anthracis, the causative agent for anthrax.  The vaccine had been approved in 1970 for pre-exposure protection of those who might be exposed to the organism, but this recent approval for use in post-exposure prophylaxis (PEP) approves the use of the vaccine in combination with selected antibiotics to significantly improve the chances of survival in patients exposed to inhaled anthrax, without the previously required use of an investigational new drug (IND) protocol.

Additional information is available from the FDA at: 

http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm474027.htm  


ALERT:  Autoinjector Shelf Life Extension Program:  Current Information

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labelled expiration dates, some up to 31 October 2019.  Complete FDA information related to the auto-injector shelf life extension program can be found at:  http://www.fda.gov/Drugs/DrugSafety/ucm376367.htm .  

Information on this page also includes the latest updates (March 2016) on shelf life
extensions for the AtroPen (atropine), CANA (diazepam), morphine sulfate, and
pralidoxime chloride auto-injectors. 

__________________________________________________________________

ADDITIONAL SURETY MEDICINE TELECONFERENCES IN FY16 
All teleconferences begin at 1 p.m. ET (US)

TOPIC

DATE 

Traumatic Brain Injuries and the PRP:  Evaluation and Disposition 

6/15/2016

 

Case Studies in PRP Management

7/20/2016

 

Urinary Metabolites, Protein Adducts, and Bio-markers of Nerve and Vesicant Agent Exposure

8/17/2016

 

Endocrine Disorders and the PRP

9/21/2016

 

_______________________________________________________________

SURETY MEDICINE REGULATIONS, GUIDANCE and USEFUL LINKS:         
(Common Access Card or Army Knowledge Online account required for access to some documents)

AR 50-1 Biological Surety: http://armypubs.army.mil/epubs/pdf/r50_1.pdf 

AR 50-5 Nuclear Surety: http://armypubs.army.mil/epubs/pdf/r50_5.pdf 

AR 50-6 Chemical Surety: http://armypubs.army.mil/epubs/pdf/r50_6.pdf 

AR 50-7 Army Reactor Program: http://armypubs.army.mil/epubs/pdf/r50_7.pdf 

DA PAM 50-5 Nuclear Accident or Incident Response and Assistance Operations: http://armypubs.army.mil/epubs/pdf/p50_5.pdf 

DA PAM 385-61 Toxic Chemical Agent Safety Standards:  http://armypubs.army.mil/epubs/pdf/p385_61.pdf

Army Directive 2013-03 (Chemical Accident or Incident Response and Assistance): http://www.apd.army.mil/pdffiles/ad2013_03.pdf

TB MED 507 Heat Stress Control and Heat Casualty Management: http://armypubs.army.mil/med/DR_pubs/dr_a/pdf/tbmed507.pdf

TB MED 590 Red Blood Cell Testing and Quality Assurance:
http://armypubs.army.mil/med/DR_pubs/dr_a/pdf/tbmed590.pdf

Medical Command (MEDCOM) Regulation 40-55 Guidance on Occupational Health Practices for the Evaluation and Control of Occupational Exposures to Biological Select Agents and Toxins: https://www.us.army.mil/suite/doc/22064586

Additional Guidance Document Sources:

Army Publishing Directorate:  http://armypubs.army.mil/index.html